CompoAtlas

Qian lie kang wan

Food supplement declared in France, declaration No 2020-4-1453, decision dated 25 April 2020

Qian lie kang wan, from Calebasse, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Coix lacryma-jobi 1.6 g per day, Citrus medica 1.15 g per day, Atractylodes lancea 0.77 g per day, Cyathula officinalis 0.77 g per day, Phellodendron amurense 0.77 g per day. 2 rules of use apply to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Calebasse
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
6 g
Not recommended (according to the manufacturer)
Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Urinary system

Declaration 302037, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Coix lacryma-jobi L.GraineExtrait sec aqueux1.6 g
Citrus medica L.FruitExtrait sec aqueux1.15 g
Atractylodes lancea (Thunb.) DC.RhizomeExtrait sec aqueux0.77 g
Cyathula officinalis K.C.KuanRacineExtrait sec aqueux0.77 g
Phellodendron amurense Rupr.EcorceExtrait sec aqueux0.77 g
Lindera aggregata (Sims) Kosterm.RacineExtrait sec aqueux0.57 g
Saponaria officinalis L.GraineExtrait sec aqueux0.38 g

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Consultez votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Qian lie kang wan: composition and regulation”, https://compoatlas.com/en/supplements/products/302037-qian-lie-kang-wan, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line